David M. Albala, MD, presented “Ablative Local Technologies (HIFU, Cryo, SBRT, Laser, and Other Forms of Energy)” during the 34th International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.

This content is available free to the GRU Community. Login or create an account to view it.


Create an Account

How to cite: Albala, David M. Ablative Local Technologies (HIFU, Cryo, SBRT, Laser, and Other Forms of Energy).” February 2024. Accessed Jun 2024. https://grandroundsinurology.com/ablative-local-technologies-hifu-cryo-sbrt-laser-and-other-forms-of-energy/

Ablative Local Technologies (HIFU, Cryo, SBRT, Laser, and Other Forms of Energy) – Summary

David M. Albala, MD, provides an overview and comparison of current options for focal ablative therapy in prostate cancer treatment. He begins by briefly discussing the benefits of focal therapy before exploring the different types of focal therapy.

Dr. Albala categorizes focal therapies into temperature-based therapies and non-temperature-based therapies. He places High Intensity Focused Ultrasound, Laser Ablation, and Cryotherapy in the temperature-based focal therapies. Radiotherapies like seed, HDR, and EBRT join Photodynamic Therapy, Radiofrequency Ablation, Electroporation, and partial prostatectomy in the non-temperature-based category.

Dr. Albala discusses the importance of weighing cancer control with the preservation of function and patient QoL when considering focal therapies. He discusses the assessment process and the rate of failure for focal therapies. He underscores the process of patient selection and treatment planning prior to selecting a therapy.

He concludes by reviewing the delivery methods currently available for focal therapy. For each method, he presents the advantages, disadvantages, and ideal patient profile for each treatment.


About The 34th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 34th iteration of the meeting occurred February 11-14, 2024 in Vail, Colorado. To view more educational presentations from IPCU 34, visit our collection page.